Department of Molecular Physiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
J Clin Invest. 2010 Dec;120(12):4425-35. doi: 10.1172/JCI40919. Epub 2010 Nov 15.
In individuals with type 1 diabetes, hypoglycemia is a common consequence of overinsulinization. Under conditions of insulin-induced hypoglycemia, glucagon is the most important stimulus for hepatic glucose production. In contrast, during euglycemia, insulin potently inhibits glucagon's effect on the liver. The first aim of the present study was to determine whether low blood sugar augments glucagon's ability to increase glucose production. Using a conscious catheterized dog model, we found that hypoglycemia increased glucagon's ability to overcome the inhibitory effect of insulin on hepatic glucose production by almost 3-fold, an effect exclusively attributable to marked enhancement of the effect of glucagon on net glycogen breakdown. To investigate the molecular mechanism by which this effect comes about, we analyzed hepatic biopsies from the same animals, and found that hypoglycemia resulted in a decrease in insulin signaling. Furthermore, hypoglycemia and glucagon had an additive effect on the activation of AMPK, which was associated with altered activity of the enzymes of glycogen metabolism.
在 1 型糖尿病患者中,低血糖是胰岛素过量的常见后果。在胰岛素诱导的低血糖情况下,胰高血糖素是肝脏葡萄糖产生的最重要刺激物。相比之下,在血糖正常的情况下,胰岛素强烈抑制胰高血糖素对肝脏的作用。本研究的首要目标是确定低血糖是否会增强胰高血糖素增加葡萄糖产生的能力。使用清醒的导管犬模型,我们发现低血糖使胰高血糖素克服胰岛素对肝葡萄糖产生的抑制作用的能力增加了近 3 倍,这种作用完全归因于对胰高血糖素净糖原分解作用的显著增强。为了研究这种作用产生的分子机制,我们分析了来自同一动物的肝活检,发现低血糖导致胰岛素信号转导减少。此外,低血糖和胰高血糖素对 AMPK 的激活具有相加作用,这与糖原代谢酶活性的改变有关。